T, Ferdinandy P. Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats. Am J Physiol Heart Circ Physiol 299: H512-H518, 2010. First published June 11, 2010; doi:10.1152/ajpheart.00052.2010We have previously shown that the inhibition of myocardial nitric oxide (NO) and peroxynitrite-matrix metalloproteinase (MMP) signaling by early preconditioning (PC) is involved in its cardioprotective effect. Therefore, in the present study, we investigated the role of NO and peroxynitrite-MMP signaling in the development of late PC. PC was performed by five consecutive cycles of 4-min coronary occlusion and 4-min reperfusion in anesthetized rats in vivo. Twenty-four hours later, hearts were subjected to a 30-min coronary occlusion followed by 180-min reperfusion to measure infarct size. In separate experiments, heart tissue was sampled to measure biochemical parameters before and 3, 6, 12, or 24 h after the PC protocol, respectively. Late PC decreased infarct size, increased cardiac inducible NO synthase (iNOS) activity and gene expression, and decreased SOD activity at 24 h significantly compared with sham-operated controls. Late PC increased cardiac superoxide levels significantly at 24 h; however, it did not change cardiac NO levels. Cardiac peroxynitrite levels were significantly decreased. Downstream cellular targets of peroxynitrite, MMP-2 and MMP-9 activities were decreased in the late PC group at 24 h compared with the sham-operated group. To verify if PC-induced inhibition of MMPs had a causative role in the reduction of infarct size, in separate experiments, we measured infarct size after the pharmacological inhibition of MMPs by ilomastat and found a significant reduction of infarct size compared with the vehicle-treated group. In conclusion, this is the first demonstration that the inhibition of cardiac peroxynitrite-MMP signaling contributes to cardioprotection by late PC and that pharmacological inhibition of MMPs is able to reduce infarct size in vivo. Furthermore, increased expression of iNOS may play a role in the development of late PC; however, increased iNOS activity does not lead to increased NO production in late PC. nitric oxide; peroxynitrite; inducible nitric oxide synthase; nitric oxide synthase; superoxide; nitrotyrosine; superoxide dismutase; ilomastat; tissue inhibitors of metalloproteinase; xanthine oxidoreductase; NADPH oxidase; gene expression MYOCARDIAL ISCHEMIC PRECONDITIONING (PC) is a phenomenon characterized by short nonlethal periods of ischemia-reperfusion that precede a prolonged ischemia, resulting in a decrease of infarct size, incidence of lethal arrhythmias, and myocardial stunning (for reviews, see Refs.
nitric oxide; peroxynitrite; inducible nitric oxide synthase; nitric oxide synthase; superoxide; nitrotyrosine; superoxide dismutase; ilomastat; tissue inhibitors of metalloproteinase; xanthine oxidoreductase; NADPH oxidase; gene expression MYOCARDIAL ISCHEMIC PRECONDITIONING (PC) is a phenomenon characterized by short nonlethal periods of ischemia-reperfusion that precede a prolonged ischemia, resulting in a decrease of infarct size, incidence of lethal arrhythmias, and myocardial stunning (for reviews, see Refs. 1, 2, and 16). Ischemic PC possesses a biphasic cardioprotective effect: an early phase immediately after the PC protocol, which lasts to ϳ1 h, and a late phase, which appears 24 h after the PC protocol and lasts for 72 h (21) .
The exact cellular mechanism of PC is still unclear. Among several other mediators, nitric oxide (NO), superoxide, and peroxynitrite have been shown by several groups to play a role in both ischemia-reperfusion injury and in the development of the cardioprotective effect of PC; however, their role have not been clearly defined (15, 23) . It has been shown that increased expression of inducible NO synthase (iNOS) plays an important role in the mechanism of late PC; however, the exact function of iNOS is still unexplained as systematic measurements of NO synthesis and elimination have not been assessed so far (6, 18) .
Peroxynitrite is a powerful oxidant species that can be formed in vivo by the nonenzymatic reaction of NO and superoxide at a rate limited only by diffusion. Tang et al. (29) suggested that peroxynitrite may contribute to the triggering mechanisms of late PC in conscious rabbits; however, no attempt has been made to measure peroxynitrite in the myocardium during the development of late PC.
The downstream cellular targets of peroxynitrite include the activation of matrix metalloproteinases (MMPs) (8, 28) , which are important contributors to myocardial ischemia-repefusion injury (8, 19, 31) . We (20) have previously described that ischemic PC reduces the ischemia-reperfusion-induced activation and release of MMP-2 in isolated rat hearts. Furthermore, we (17) have shown that the acute inhibition of MMP-2 reduces infarct size in rat hearts. However, the exact role of MMPs in the development of late PC is still unknown.
Therefore, in the present study, we investigated the role of NO and peroxynitrite-MMP signaling by the systematic analysis of NO, superoxide, and peroxynitrite formation, their enzymatic production and breakdown, and the gene expression of relevant enzymes as well as MMP activation during the development of late PC in rats in vivo.
MATERIALS AND METHODS
This investigation conformed with the National Institutes of Health's Guide for the Care and Use of Laboratory Animals (NIH Pub. No. 85-23, Revised 1996) and the experimental protocol was approved by the local Animal Ethics Committee of the University Szeged.
Experimental protocol. A late PC protocol was used to reduce infarct size in male Wistar rats housed in individually ventilated cages and fed standard rat chow and water ad libitum. Animals were preconditioned by five consecutive cycles of 4 min of ischemia and 4 min of reperfusion. Twenty-four hours after the PC protocol, 30 min test ischemia followed by 180 min of reperfusion were performed. The control group was subjected to the same procedures without the PC protocol (Fig. 1A) .
For the investigation of the biochemical parameters and gene expression changes during the development of late PC, nine further experimental groups were used in separate experiments (Fig. 1B) . A group of animals without any treatment served as the 0-h control. Four separate groups were preconditioned, and 3, 6, 12, or 24 h after the PC protocol, hearts were isolated, perfused for 5 min on a Langendorff system to remove blood, and then frozen in liquid nitrogen. Four separate sham-operated control groups underwent the same procedures as the PC groups, but no occlusion was performed with the suture in these groups; 3, 6, 12, and 24 h later, hearts were then sampled. Frozen hearts were powdered and homogenized in four volumes of ice-cold homogenization buffer (for composition, see Ref. 25 ) with an ultrasonic homogenizator.
Finally, after the evaluation of biochemical parameters in the experimental groups above, to verify if late PC-induced inhibition of MMPs has a causative role in the reduction of infarct size, in separate experiments, 30 min of test ischemia followed by 120 min of reperfusion were applied after treatment with 1.5 mol/kg ilomastat, a nonselective MMP inhibitor, and vehicle, respectively. Ilomastat and its vehicle were administered 5 min before the coronary occlusion and at the 10th and 25th min of ischemia as well as at the 10th min of reperfusion to maintain its plasma level (Fig. 1C) .
Induction of myocardial infarction. Myocardial infacrtion was induced as originally described by Selye et al. (26) . Briefly, male Wistar rats were anesthetized with 50 mg/kg pentobarbital sodium (Euthanyl, Bimeda-MTC Animal Health, Cambridge, ON, Canada). Animals were intubated and ventilated with a rodent respirator (Harvard Apparatus, Holliston, MA) using room air (tidal volume: 2.5 ml, 53 Ϯ 3 breaths/min). Body temperature was monitored during the experiments and maintained at 37°C by placing the animals on a heating pad. The heart was exposed through a left thoracotomy in the fourth intercostal space. A 5-0 monofil atraumatic suture (Prolene, Ethicon, Somerville, NJ) was passed around the major branch of the left coronary artery, ϳ2 mm from its origin. A small plastic knob (diameter of ϳ5 mm) was threaded through the ligature and placed in contact with the heart. Both ends of the prolene suture were passed through a small vinyl tube and exteriorized. The heart was replaced in the chest, and the occlusion was carried out by a hemostat that pressed the tube and the knob to the myocardium. The PC protocol was performed by five cycles of 4-min occlusions, each followed by 4 min of reperfusion. Sham-operated rats underwent identical procedures without occlusion of the artery. The chest was closed in layers, and all rats were allowed to recover after surgery. The electrocardiogram was monitored throughout the experiments; correct placement of the ligature was verified by the appearance of an acute elevation of the ST segment during the occlusion.
To estimate infarct size after coronary occlusion, hearts were isolated and perfused for 5 min in a Langendorff system to wash out the blood. The coronary artery was then reoccluded, and hearts were perfused with 0.1% Evans blue. After being stained with Evans blue, hearts were frozen, cut into slices, and incubated in 1% 2,3,5-triphenyltetrazolium chloride for 10 min at 37°C. Slices were scanned, and the size of the infarcted area related to the area at risk was determined by computer planimetry (Infarctsize, Pharmahungary Group, Szeged, Hungary).
Measurements of cardiac NO and NOS. To measure cardiac NO content directly, ex vivo spin trapping of NO was applied in separate experiments ( Fig. 1) followed by electron spin resonance (ESR) analysis of left ventricular tissue samples as previously described (12, 22) . In brief, the spin trap N-methyl-D-glucaminedithiocarbamate (MGD; 175 mg/kg), 50 mg/kg FeSO4, and 200 mg/kg sodium citrate were dissolved in 6 ml of distilled water (Millipore). After 5 min of Langendorff perfusion, ventricular samples were minced into small pieces and incubated in MGD-FeSO4-sodium citrate solution for 10 min under inert N2 gas to avoid oxidation. Ventricular samples were then dried on blotting paper and placed into quartz ESR tubes and frozen in liquid nitrogen until being assayed for ESR spectra of the NO-Fe 2ϩ -MGD complex at a temperature of 160 K (Bruker ECS106, Rheinstetten, Germany).
In separate experiments, animals (n ϭ 6) were treated with an intraperitoneal injection of 1 mg/kg N- [3-(aminomethyl) benzyl]acetamidine (1400W), a selective iNOS inhibitor, or vehicle saline 23 h after PC. Cardiac NO content was measured at 24 h to estimate the role of iNOS in cardiac NO production in late PC.
To estimate endogenous enzymatic NO production, Ca 2ϩ -dependent and Ca 2ϩ -independent NOS activities in ventricular homogenates were measured by the conversion of [L- 14 C]arginine to [L- 14 C]citrulline as previously described (14) . Ventricular homogenates were centrifuged (1,000 g for 10 min) at 4°C, and the supernatant was kept on ice for the immediate assay of enzyme activities. Samples were incubated for 25 min at 37°C in the presence or absence of EGTA (1 mM) or EGTA plus N G -monomethyl-L-arginine (1 mM) to determine the level of Ca 2ϩ -dependent and Ca 2ϩ -independent NOS activities, respectively. NOS activities were expressed in picomoles per minute per milligram of protein.
Measurements of cardiac superoxide metabolism. In situ detection of the superoxide anion was performed by confocal laser scanning microscopy using the fluorescent dye dihydroethidium (Sigma) as previously described (4, 10) . Dihydroethidium is freely permeable to cell membranes and emits a red fluorescent signal when oxidized by superoxide. Frozen native heart sections (30 m) were placed on glass slides covered with PBS buffer (pH 7.4) and collected at 4°C. Slides were then submerged in 1 mol/l dihydroethidium (Sigma) in PBS buffer (pH 7.4) and incubated at 37°C for 30 min in a dark humidified container. Fluorescence in heart sections was detected by a confocal microscope (Olympus FV1000) using a 530-nm long-pass filter for excitation. Images of the hearts that had been treated with saline (negative control) were measured first. After the basal settings of the confocal microscope were adjusted, images of the hearts were collected digitally. Eight images were taken randomly of each of the slides, and fluorescence intensity was analyzed using the ImageJ 129 program.
The activities of xanthine oxidoreductase (XOR; xanthine oxidase and xanthine dehydrogenase) and NADPH oxidase, major sources of superoxide in rat hearts, were determined from ventricular homogenates. XOR activity was determined by a fluorometric kinetic assay based on the conversion of pterine to isoxanthopterine in the presence (total XOR activity) or absence (XOR activity) of the electron acceptor methylene blue, as previously described (3, 11) . NADPH oxidase activity was measured by a chemiluminescence assay (14) in KrebsHenseleit solution containing 0.25 mol/l HEPES (pH 7.4), 5 mol/l lucigenin, and 30 l of tissue homogenate in 1 ml of total volume using a Packard-Bell liquid scintillation counter in out-of-coincidence mode. The increase in luminescence signal was monitored for 5 min after the addition of 100 mol/l NADPH. Ventricular homogenates were prepared as for the measurements of NOS activity.
The total activity of SOD was measured by a spectrophotometric assay using a kit (RanSOD, Randox Laboratories, Crumlin, UK). Approximately 50 mg ventricular tissue were homogenized in 10ϫ volumes of ice-cold phosphate buffer (0.01 M, pH 7.0). SOD activity in homogenates was determined by the inhibition of formazan dye formation due to superoxide generated by xanthine and xanthine oxidase (22) .
Measurements of cardiac peroxynitrite. To estimate cardiac peroxynitrite formation, we measured free nitrotyrosine by ELISA (Cayman Chemical, Ann Arbor, MI) in myocardial homogenates as previously described (11, 14) . Briefly, tissue samples were deproteinized by the addition of 4 volumes of ice-cold ethanol. After centrifugation, supernatants were evaporated in nitrogen flow and dissolved in phosphate buffer. Deproteinized ventricular homogenates were incubated overnight with anti-nitrotyrosine rabbit IgG and nitrotyrosine acetylcholinesterase tracer in precoated (mouse anti-rabbit IgG) microplates followed by development with Ellman's reagent.
Zymographic analysis of MMP activity. To measure myocardial MMP-2 and MMP-9 activities, we collected ventricular tissue according to the Experimental protocol section. Tissue was homogenized in the absence of any protease inhibitor. Gelatinolytic activities of MMPs were examined as previously described (17) . Briefly, 8% polyacrylamide gels were copolymerized with gelatin (2 mg/ml, type A from porcine skin, Sigma-Aldrich), and 40 g of protein per lane were loaded. An internal standard (supernatant of phorbol esteractivated HT-1080 cells, American Type Culture Collection, Manassas, VA) was loaded into each gel to normalize activities between gels. After electrophoresis (150 V, 1.5 h), gels were washed with 2.5% Triton X-100 for 3 ϫ 15 min and incubated for 24 -48 h at 37°C in incubation buffer (50 mM Tris·HCl, 150 mM NaCl, 5 mM CaCl2, and 0.05% NaN3, pH 7.4). Gels were then stained with 0.05% Coomassie brilliant blue (G-250, Sigma-Aldrich) in a mixture of methanol-acetic acid-water [2.5:1:6.5 (vol/vol)] and destained in aqueous 4% methanol-8% acetic acid (vol/vol). Gelatinolytic activities were detected as transparent bands against the dark-blue background. Zymograms were digitally scanned, and band intensities were quantified using Quantity One software (Bio-Rad, Hercules, CA) and expressed as the ratio to the internal standard. Band density was expressed in arbitrary units.
Quantitative real-time PCR. Quantitative real-time PCR was performed on a RotorGene 3000 instrument (Corbett Research, Sydney, Australia) with gene-specific primers and the SYBR green protocol to assess expression changes of NOS, MMP, and tissue inhibitor of metalloproteinase (TIMP) genes. Two micrograms of total RNA from each sample were reverse transcribed in the presence of random primers in a total volume of 20 l.
A nontemplate control sample was used for each PCR run to check for the genomic DNA contaminations of the cDNA template. Analysis of results was done using the Pfaffl method (24, 33) . With the use of this calculation method, differences between the amplification efficiencies of reactions could be corrected.
Statistical analysis. Data are expressed as means Ϯ SE or SD and were analyzed with an unpaired t-test or one-way ANOVA followed by Tukey's post hoc test as appropriate. Two-way ANOVA was performed to study the time course of enzymatic changes to determine the possible interactions between time dependence and late PC. P values of Յ0.05 were accepted as statistically significant differences compared with the control or sham-operated control group.
RESULTS
Infarct size. We measured infarct size to verify the cardioprotective effect of late PC in our model of rat coronary occlusion and reperfusion. We found that late PC reduced infarct size significantly (P Ͻ 0.01) compared with shamoperated controls (Fig. 2) .
Myocardial NO and superoxide metabolism. We determined Ca 2ϩ -dependent and Ca 2ϩ -independent NOS activities and the gene expression of NOS in the rat myocardium and measured cardiac NO levels to investigate the role of NO formation during the development of ischemic late PC. Ca 2ϩ -dependent NOS activity and expression levels of endothelial and neuronal NOS remained unchanged (Fig. 3A and Table 1 ). However, Ca 2ϩ -independent NOS activity increased gradually after the PC protocol, and at 12 h, the elevation reached the level of significance and further increased by 24 h. iNOS mRNA content measured at 24 h was also increased significantly compared with the sham-operated group; however, the gene expression of other NOS isoforms remained unchanged ( Fig.  3B and Table 1 ). Despite the increased iNOS expression and activity, the NO signal did not change during the development of late PC.
Therefore, in separate experiments, we measured cardiac NO after late PC in the presence of 1400W, a selective iNOS inhibitor, to test the contribution of iNOS to cardiac NO generation. iNOS inhibition did not reduce the amount of cardiac NO in PC hearts (160.3 Ϯ 45.1 vs. 164.5 Ϯ 45.1 arbitrary units in the presence or absence of 1400W, respectively).
XOR and NADPH oxidase (major enzymes producing superoxide in the rat heart) activities were measured to estimate enzymatic superoxide generation during late PC. We observed a gradual increase of XOR and NADPH oxidase activities in both PC and sham-operated groups compared with the 0-h control group; however, there were no differences between PC and sham-operated groups (Fig. 4, A and B) . The activity of total SOD, which is responsible for the elimination of superoxide, was measured by a photometric assay to determine the superoxide decomposition during the development of late PC. A significant decrease of myocardial total SOD activity was found in the PC group 24 h after the PC protocol (Fig. 4B) compared with the 0-h control group and 24-h sham-operated group, respectively. We compared myocardial superoxide content in the PC and sham-operated groups and found a significant elevation 24 h after the PC protocol, when cardiac superoxide was measured by dihydroethidium staining (Fig. 4C) .
Myocardial peroxynitrite and activation of MMPs. We determined myocardial nitrotyrosine contents in the PC and sham-operated groups 24 h after the PC protocol by ELISA to estimate peroxynitrite generation. Peroxynitrite generation was significantly attenuated compared with the sham-operated group 24 h after PC (Fig. 5A) .
Zymography was performed to measure changes in the activity of MMP-9 and MMP-2, which are characteristic MMPs of the myocardium. Both MMP-9 ( Fig. 5B ) and MMP-2 ( Fig. 5C ) activities showed a significant reduction 24 h after the PC protocol compared with sham-operated animals. Ischemic late PC resulted in a decrease in the gene expression of MMP-2; however, the amount of MMP-9 mRNA was increased. Gene expressions of TIMP1, TIMP2, and TIMP4 were not changed; however, TIMP3 mRNA showed a significant decrease in the PC group compared with the sham-operated group (Table 1) .
Effect of the MMP inhibitor ilomastat on infarct size. Ilomastat, a nonselective MMP inhibitor, was used to verify if PC-induced inhibition of MMP activity has a causative role in the reduction of infarct size. Ilomastat (1.5 mol/kg) given 5 min before ischemia, followed by infusion to maintain plasma concentration during ischemia and the first 10 min of reperfu- Values are means Ϯ SE for fold changes in the 24-h preconditioned (PC) group compared with the 24-h sham-operated group; n ϭ 4 animals/group. NOS, nitric oxide synthase; MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase. *Significantly upregulated genes; †significantly repressed (downregulated) genes. sion, decreased infarct size significantly compared with vehicle-treated animals (Fig. 6) .
DISCUSSION
In the present study, we studied the role of peroxynitrite-MMP signaling in late PC by the systematic analysis of metabolism of NO, superoxide, and peroxynitrite as well as MMPs in the myocardium in a late PC model of rats with coronary occlusion in vivo. We showed that PC increased the expression and activity of iNOS and decreased peroxynitrite formation and the activation of MMPs. To verify if late PC-induced inhibition of peroxynitrite-MMP signaling had a causative role in infarct size reduction, we showed that pharmacological inhibition of MMP activity was able to reduce infarct size in this model. Therefore, this is the first demonstration that late PC-induced cardioprotection is at least in part due to the inhibition of peroxynitrite-MMP signaling. Furthermore, we confirmed that late PC increased iNOS expression; however, surprisingly, cardiac NO formation was not increased, but cardiac superoxide was elevated. This may suggest that the role of iNOS in late PC is not mediated by increased NO production.
We (9, 20) have previously shown that the inhibition of peroxynitrite-MMP signaling is involved in the cardioprotective effect of early PC. Therefore, in the present study, we studied the role of the peroxynitrite-MMP signaling in late PC by the systematic analysis of NO, superoxide, and peroxynitrite formation and breakdown as well as MMP activation, including gene expression and enzyme activity assays during the evolution of the protective effect of late PC.
In the present study, we confirmed that the cardioprotective effect of ischemic late PC was accompanied by the induction of iNOS, as previously described by several studies (5, 7, 15) . However, in the present study, surprisingly, iNOS activation did not lead to increased NO levels in the myocardium, as measured by ESR spectroscopy 24 h after the PC stimulus. These findings show that the role of iNOS in late PC may be not related to increased NO production. This is further supported by the finding that 1400W, a selective iNOS inhibitor, did not decrease cardiac NO content at late PC in our present study.
It is now understood that many of the actions of NO are not directly due to NO itself but are mediated via the production of peroxynitrite, the reaction product of NO with superoxide (13, 23) . Therefore, we examined myocardial levels of superoxide and peroxynitrite as well as the expression and activity of the enzymes involved in superoxide production and its elimination. We found markedly increased superoxide levels in the myocardium 24 h after PC compared with the non-PC group. Neither XOR activity nor NADPH oxidase activities were changed; however, SOD activity was decreased 24 h after the PC stimulus compared with non-PC controls. These results show that the source of increased myocardial superoxide could be decreased activity of SOD. Moreover, it is well known that iNOS is able to produce superoxide in certain circumstances, e.g., in the absence of tetrahydrobiopterin and/or L-arginine (32) and an altered ratio of ROS and reactive nitrogen species (27) . Therefore, since NO production was not increased in the present study, increased iNOS activity could be another source of increased superoxide levels during late PC, although further analysis of this hypothesis was out of the scope of the present study.
We (9) have previously shown that peroxynitrite may trigger classic ischemic PC and that subsequent cycles of ischemiareperfusion result in a gradual decrease in peroxynitrite formation. However, no attempt has been made so far to measure cardiac peroxynitrite during late PC in the literature, although peroxynitrite is suspected to be a trigger of late PC in conscious rabbits based on indirect evidence obtained using a nonspecific antioxidant (29) . In the present study, we measured cardiac nitrotyrosine levels as a marker of cardiac peroxynitrite generation and showed, for the first time in the literature, that late PC significantly diminishes myocardial peroxynitrite. It has been previously described that peroxynitrite activates MMPs, which may play a role in a variety of cardiovascular pathologies including ischemia-reperfusion injury (8) . We have previously shown that early PC reduces MMP-2 release to the perfusate (20) and, more recently, that the inhibition of MMPs by ilomastat reduces infarct size in isolated rat hearts both under normal and hyperlipidemic conditions (17) . However, it was not known if the inhibition of MMPs by late PC is involved in its cardioprotective effect. In the present study, we showed that the activities of both major cardiac MMPs, MMP-2 and MMP-9, significantly diminished during ischemic late PC. To study if PC-induced MMP inhibition has a causative role in its infarct size reduction, in separate experiments, rats were treated with the nonselective MMP inhibitor ilomastat during coronary occlusion and reperfusion. We showed that the pharmacological inhibition of MMPs also produces a reduction in infarct size in the rat infarction model in vivo. To study if increased TIMPs inhibit MMPs, we measured the gene expression of four isoforms of TIMPs. As gene expressions of TIMP1, TIMP2, and TIMP4 were not changed and that of TIMP3 was decreased, MMP inhibition by altered TIMP levels is unlikely; nevertheless, the role of TIMPs in late PC cannot be excluded (30) . Therefore, it is plausible to speculate that the inhibition of MMP activity is due to a decreased activation of MMPs by a PC-induced decrease in peroxynitrite. These results show that late PC-induced inhibition of peroxynitrite-MMP signaling is involved in the cardioprotective effect of late PC and that the pharmacological inhibition of MMPs is able to reduce infarct size in vivo.
Although our results provide several mechanistic data to support the hypothesis that late PC-induced inhibition of peroxynitrite-MMP signaling is involved in the mechanism of late PC, there are some limitations to the present study. Although we measured cardiac NO directly with ESR spectroscopy, quantitative measurement of cardiac NO in vivo is not possible due to several technical reasons (18) . Due to its very short half-life at physiological pH, the endogenous formation of peroxynitrite cannot be directly detected in biological systems. Therefore, to estimate cardiac peroxynitrite formation, we measured cardiac nitrotyrosine, a relatively specific marker for Fig. 6 . Effect of the nonselective MMP inhibitor ilomastat on infarct size after 30 min of ischemia followed by 120 min of reperfusion. Values are means Ϯ SE; n ϭ 7 animals in the vehicle-treated group and 8 animals in the ilomastat-treated group. *P Ͻ 0.05 vs. the vehicle-treated group. peroxynitrite formation (13) . To prove the direct link between MMP inhibition and the cardioprotective effect of late PC, additional experiments in conditional MMP2-overexpressing animals would be necessary, which are currently unavailable according to our best knowledge. To limit the number of biochemical measurements, we measured cardiac NO, superoxide, peroxynitrite, and MMP at 24 h after the PC stimulus; therefore, the time course of changes of these biochemical parameters during the evolution of late PC remain unknown.
Taken together, in the present study, we showed that late PC decreases cardiac peroxynitrite levels and MMP activity and that the pharmacological inhibition of MMP activity is able to reduce infarct size. This is the first demonstration that late PC-induced inhibition of peroxynitrite-MMP signaling is involved in cardioprotection by late PC and that pharmacological MMP inhibition is able to reduce infarct size in vivo. Furthermore, we showed here that late PC is associated with increased iNOS and decreased SOD activity, which is accompanied by increased cardiac superoxide levels but no change in NO levels. One may speculate that iNOS-induced superoxide formation also plays a role in the mechanism of late PC. Finally, we pointed out a new opportunity for the treatment of ischemic heart diseases by inhibition of MMPs. 
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the author(s).
